NDC 70842-225
Kimyrsa 1200 mg per 40 mL injection, powder, lyophilized, for solution
On the label: Melinta Therapeutics, LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| AbbVie Inc. | North Chicago, IL, United States | Makes the active ingredient and tests it | No problems foundMar 3, 2026 · 10 inspections |
| BioConvergence LLC DBA Singota Solutions | Bloomington, IN, United States | Makes it | No problems foundJun 29, 2010 · 1 inspection |
| Patheon Italia S.p.A. | Monza, Italy | Makes it, tests it and packages it | Problems found, fixed voluntarilyMay 26, 2023 · 10 inspections |
| Frontage Laboratories, Inc. | Exton, PA, United States | Tests it | Problems found, fixed voluntarilyJun 18, 2026 · 14 inspections |
| PPD Development, L.P. | Middleton, WI, United States | Tests it | Problems found, fixed voluntarilySep 25, 2025 · 6 inspections |
| Pharma Packaging Solutions, LLC | Clinton, TN, United States | Packages it and labels it | No problems foundJun 28, 2023 · 4 inspections |
Product details
- Generic drug
- Oritavancin: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 1200 mg per 40 mL
- Approval
- NDA NDA214155
- On the market since
- Mar 23, 2021
- Package NDCs
70842-225-01- Official label
- DailyMed (National Library of Medicine), updated Dec 18, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?